Beijing Zhongke Kang Xue Institute of Hematology (hereinafter referred to as Beijing Institute of Hematology) is a scientific research institution with distinctive characteristics of traditional Chinese medicine, which mainly produces and develops traditional Chinese medicine preparations. 20 10, relying on clinical research data and clinical rehabilitation cases, China National Intellectual Property Administration applied for a drug patent, 20 1 10, and officially passed the issuance of a drug patent certificate. Successfully developed drugs for hematological diseases (thrombocytopenia, thrombocytosis, Henoch-Schonlein purpura, leukemia, aplastic anemia, myelodysplastic syndrome, polycythemia vera, multiple myeloma).
The patentees are Shi, Xie Bielu, Hu Guisheng, Zhan, Liao Zuoqin.
Because Beijing Institute of Hematology is a scientific research institution, there are three cooperative medical hospitals as designated clinical units, one in Daxing District, one in Fengtai District and one in Xicheng District.
The branches are located in Daxing District, Fengtai District and Xicheng District. Local citizens should arrange their time reasonably and go to the nearest branch.